IRIS
TIRRI, Rosella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.719
NA - Nord America 2.256
AS - Asia 1.872
SA - Sud America 338
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 1
Totale 15.220
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.407
US - Stati Uniti d'America 2.217
RU - Federazione Russa 979
SG - Singapore 679
IE - Irlanda 558
CN - Cina 430
UA - Ucraina 392
FR - Francia 313
BR - Brasile 291
GB - Regno Unito 286
HK - Hong Kong 260
NL - Olanda 220
DE - Germania 182
KR - Corea 169
VN - Vietnam 95
TR - Turchia 92
FI - Finlandia 91
SE - Svezia 73
GR - Grecia 67
IN - India 51
JP - Giappone 41
ES - Italia 33
CH - Svizzera 26
BE - Belgio 20
CA - Canada 20
PL - Polonia 20
AR - Argentina 16
AT - Austria 13
EC - Ecuador 12
ID - Indonesia 11
BD - Bangladesh 10
ZA - Sudafrica 10
RO - Romania 9
MX - Messico 8
CO - Colombia 6
HR - Croazia 6
TW - Taiwan 6
EU - Europa 5
LT - Lituania 5
MA - Marocco 5
PK - Pakistan 5
PE - Perù 4
RS - Serbia 4
UZ - Uzbekistan 4
VE - Venezuela 4
DO - Repubblica Dominicana 3
HU - Ungheria 3
IQ - Iraq 3
KE - Kenya 3
KZ - Kazakistan 3
AL - Albania 2
AP - ???statistics.table.value.countryCode.AP??? 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EG - Egitto 2
GT - Guatemala 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
PH - Filippine 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
ET - Etiopia 1
GE - Georgia 1
IL - Israele 1
LB - Libano 1
MK - Macedonia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SM - San Marino 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.220
Salva come PNG Salva come JPEG
Città #
Dublin 552
Rome 510
Jacksonville 463
Milan 411
Santa Clara 347
Moscow 320
Singapore 299
Hong Kong 259
Chandler 253
Naples 176
Seoul 169
Florence 94
Palermo 90
Turin 86
Princeton 85
Ann Arbor 81
Catania 65
Medford 63
Nanjing 62
Bari 59
Bologna 54
Roxbury 54
Hefei 53
Boardman 50
Padova 49
Beijing 48
San Mateo 43
Napoli 41
Woodbridge 41
Ashburn 39
Dallas 39
Verona 39
The Dalles 38
Caserta 37
Wilmington 37
Genoa 34
Cambridge 33
Bengaluru 28
Taranto 25
Torino 25
Brescia 23
Cagliari 23
Hanoi 23
Ho Chi Minh City 23
Pescara 23
Messina 22
Livorno 20
Venice 20
Des Moines 19
Parma 19
Vicenza 19
Como 18
Genova 18
Perugia 18
Trieste 18
Los Angeles 17
Modena 17
Düsseldorf 16
São Paulo 16
Brussels 15
Gorno 15
Reggio Emilia 15
Reggio Calabria 14
Salerno 14
Kunming 13
Nanchang 13
New York 13
Redwood City 13
Trento 13
Belluno 11
Bergamo 11
Bolzano 11
Bremen 11
Mountain View 11
Nuremberg 11
Rimini 11
Terni 11
Varese 11
Catanzaro 10
Hanover 10
Helsinki 10
Mykolayiv 10
Prato 10
Bastia umbra 9
Cosenza 9
Guangzhou 9
Houston 9
Lecce 9
Lucca 9
Marano Di Napoli 9
Sassari 9
Assisi 8
Auburn Hills 8
Carbonera 8
Latina 8
Munich 8
Ottawa 8
Pavia 8
Porto Alegre 8
Rio de Janeiro 8
Totale 6.054
Salva come PNG Salva come JPEG
Nome #
ARTRITE PSORIASICA ED INTERSTIZIOPATIA POLMONARE : DESCRIZIONE DI UN CASO CLINICO. 7.855
ANTI TNF ALFA IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE E SPONDILOARTRITI HBV CARRIERS OCCULTI:STUDIO RETROSPETTIVO SULLA SICUREZZA 247
RAPPORTO TRA QUALITÀ DEL SONNO E DOLORE CRONICO IN PAZIENTI CHE ACCEDONO PER LA PRIMA VOLTA AD UN AMBULATORIO SPECIALISTICO DI REUMATOLOGIA R. Ferrara, D. Capocotta, R. Tirri 235
CROSSLINKS PIRIDINICI URINARI IN PAZIENTI AFFETTI DA SCLEROSI SISTEMICA 152
MANIFESTAZIONI OCULARI NELLA POLI-DERMATOMIOSITE 139
Antinuclear antibodies in first-degree relatives of patients with polymyositis-dermatomyositis: analysis of the relationship with HLA haplotypes 138
ANTI-TNFα TREATMENT IS ASSOCIATED WITH INCREASED LIVER STIFFNESS IN HBV OCCULT CARRIER PATIENTS 132
Evidence for bone resorption in systemic sclerosis 130
ESCREZIONE URINARIA DI PIRIDINOLINE IN PAZIENTI DI SCLEROSI SISTEMICA E LUPUS ERITEMATOSO SISTEMICO 127
TERAPIA DEL LUPUS ERITEMATOSO SISTEMICO CON MEGADOSI DI METILPREDNISOLONE. RISULTATI ED EFFETTI COLLATERALI IN 14 PAZIENTI. 123
INCREASED LEVES OF URINARY PYRIDINIUM CROSSLINKS OF COLLAGEN IN SYSTEMIC SCLEROSIS. 120
CROSSLINKS DEL COLLAGENE NELLE URINE DI PAZIENTI SCLERODERMICI: RISULTATI PRELIMINARI 115
ASSOCIAZIONE CIRROSI BILIARE PRIMITIVA (CBP)/SCLEROSI SISTEMICA SINE SCLERODERMIA (Ssss). 111
Rosacea and abatacept: the first report of a possible correlation 109
[The nephrotic syndrome and pheochromocytoma. A report of a rare clinical case] 103
PREVALENCE OF ANTIBODIES RECOGNAIZING CYCLIC CITRULLINATED PEPTIDE(anti CCP) IN PATIENTS WITH ULCERATIVE COLITIS 101
. ERYTHEMA YRATUM REPENS AND RHEUMATOID ARTHRITIS:CONNECTED FOR THE FIRST TIMe 100
ARTHRITIS IS ASSOCIATED WITH PSORIASIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 99
ANTINUCLEAR ANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSIS: FANA AND ANTIBODIES TO ENA. 99
.ANTI-TNF alfa IN PATIENTS WITH EITHER RHEUMATOID ARTHRITIS OR SPONYLOATHRITIS And CONCURRENT C HEPATITIS:A RETROSPECTIVE RECORD REVIEW ON SAFETY 97
[Cardiac changes in dermatomyositis] 96
METHYPREDNISOLONE PULSE THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS (A STUDY OF 11 CASES 96
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 96
ASPETTI CLINICO-EVOLUTIVI IN 44 CASI DI POLIMIOSITE/ DERMATOMIOSITE 95
Evidence for peripheral impaired glucose handling in patients with connective tissue diseases 94
Cardiac involvement in rheumatoid arthritis: an echocardiographic study 93
30. SULLA EFFICACIA E TOLLERABILITA DELLACQUA MEDIO-MINERALE FONTE LILIA IN PAZIENTI DISPEPTICI ED IPERURICEMICI. 92
Absence of elevated creatine kinase in dermatomyositis does not exclude malignancy 90
Erythema gyratum repens and rheumatoid arthritis: an unrecognized association? 90
Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus. 89
Aspetti recenti del termalismo in Campania 88
ANTI-TOPOISOMERASE I (ANTI-SCL-70) AND CANCER IN SYSTEMIC SCLEROSIS. ARE THEY RELATED? 87
RELAPSING POLYCHONDRITIS. AN HYSTOCHEMICAL STUDY BY LECTIN. 85
ANTICORPI ANTICARDIOLIPINA ED ABORTO ABITUALE IN ASSENZA DI ALTRE CAUSE FAVORENTI 85
Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: Results of an Italian observational study 85
[The effect of water with medium mineral content on various biohumoral parameters of uric acid metabolism] 83
[Electromyographic studies in patients with progressive systemic sclerosis] 82
IMPIEGO DELLA FANGOBALNEOTERAPIA ALLA LUCE DELLE RECENTI ACQUISIZIONI SULLA CLINICA DELLE MALATTIE REUMATICHE 82
[Clinico-developmental aspects in 44 cases of polymyositis/dermatomyositis] 82
Analisi delle modalità di afferenza e delle caratteristiche cliniche di pazienti con Fenomeno di Raynaud al primo accesso in un ambulatorio specialistico di reumatologia. 82
Succesfull neridronate therapy in transient osteoporosis of the hip 81
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 79
COGANS SYNDROME: A CASE REPORT. 77
Cerebral atrophy in SLE patients: a consequence of steroid treatment? 76
CK MB ED ISOENZIMI 1 E 2 DELLA LAD NELLA PM/DM. 75
Leflunomide in psoriatic arthritis: a retrospective study of discontinuation rate in daily clinical practice compared with methotrexate. 74
SUL COMPORTAMENTO DELLA DENSITA MINERALE RADIALE NEGLI OBESI. 73
EFFICACIA TERAPEUTICA DI UNA NUOVA ACQUA OLIGOMINERALE (SORGENTE FONTEVERDE) IN PAZIENTI GOTTOSI. 72
Incidence of microalbuminuria in obese hypertensive subjects 72
False positivity of prenatal Down's syndrome and neural-tube tests in SLE 72
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVES TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES 71
INCIDENZA DI REAZIONI AVVERSE IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE IN TERAPIA CON UN PRIMO E/O UN SECONDO ANTI TNF ALFA 71
GOTTA: EVOLUZIONE NON CONTROLLATA NELL’ERA DELL’APPROCCIO “TREAT TO TARGET SERUM URATE” 71
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 71
Mediterranean Symposium of rheumatology 70
safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice 69
Evaluation of microalbuminuria in obese subjects with preserved renal function 69
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVE TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES. 69
MANIFESTAZIONI OCULARI IN GIOVANI ED ADULTI AFFETTI DA MALATTIE REUMATICHE 69
VALUTAZIONI CLINICO-NEUROFISIOLOGICHE IN PAZIENTI CON SCLEROSI SISTEMICA PROGRESSIVA 69
VALUTAZIONI ECOCARDIOGRAFICHE NEI SOGGETTI OBESI. 68
CEREBRAL ATROPHY IN SLE PATIENTS: A CONSEQUENCES OF STEROID TREATMENT ? 68
The relationship among pain sleep disorders and smoke in patients who assess for the first time in a Rheumatology Unit 68
EFFECTS OF A REHABILITATION PROGRAM IN FIBROMYALGIA PATIENTS IN PHARMACOLOGICAL TREATMENT 68
IPERSONNOLENZA IN PAZIENTI CON MALATTIE REUMATICHE COMUNEMENTE ASSOCIATE A DOLORE D. Capocotta, R. Ferrara, R. Tirri 67
Foot involvement in systemic sclerosis: a longitudinal study of 100 patients 66
DRUG SURVIVAL OF THE FIRST COURSE OF ANTI-TNF AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SERONEGATIVE SPONDYLOARTHRITIS: ANALYSIS FROM THE MONITORNET DATABASE. 66
LONG TERM SAFETY OF ANTI -TNF ALFA IN PATIENTS WITH INFLAMMATORY ARTHRITIS AND HBV INFECTION: FOCUS ON HEPATITIS B SURFACE ANTIBODY STATUS 65
EPIDEMIOLOGIA E PREVENZIONE DELLE MALATTIE REUMATICHE 65
Sclerosi sistemica 65
Adult onset Still s Disease:a rare paraneoplastic Syndrome? 65
Pott's disease of the lower cervical spine in a diabetic patient 64
POLYMYOSITIS ASSOCIATED WITH OTHER CONNECTIVE TISSUE DISEASES: NEUROPHYSIOLOGICAL STUDY OF 7 CASES 63
UTILITA DELLA TOMOGRAFIA ASSIALE COMPUTERIZZATA CRANIO-CEREBRALE NEL LUPUS ERITEMATOSO SISTEMICO. 63
Clinical pattern of pain in rheumatoid arthritis 62
L’IMPEGNO MUSCOLARE NELLA FASCITE EOSINOFILA: STUDIO ELETTROFISIOLOGICO IN 2 CASI. 62
RELEVANCE OF ELECTROPHYSIOLOGICAL INVESTIGATIONS IN SISTEMIC SCLEROSIS 62
TNF alfa inhibitors and tocilizumab do not influence hepatic steatosis in patients with Rheumatoid arthritis 61
QUALITY OF LIFE AND UNMET NEEDS IN PATIENTS WITH INFLAMMATORY ARTHROPATHIES RESULTS FROM THE MULTICENTER, OBSERVATIONAL RAPSODIA STUDY. 60
The predictive value of attributes of pain to classify rheumatoid arthritis 60
SLEEP DISORDERS IN PATIENTS AT THE FIRST ACCESS TO A RHEUMATHOLOGY OUTPATIENT Clinic 60
OCULAR INVOLVEMENT IN POLYMYOSITYS/DERMATOMYOSITIS 57
Un raro caso di artrite post infettiva associata ad ascaridiasi 57
DRUG SURVIVAL OF THE FIRST COURSE OF ANTI-TNF AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SPONDYLOARTHROPATHIES. RESULTS FROM THE MONITORNET DATABASE 56
RS3PE e Diabete Mellito di tipo 2: utilità diagnostica dell’Ultrasonografia 52
The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis 49
The contribute of sleep quality and mood disturbances on pain perception in patients with rheumatic diseases at first access 48
The measurement of fibromyalgia severity: converting scores between the FIQR, the PSD and the FASmod 45
null 45
Incidental papillary thyroid cancer diagnosis in patientwith adult onset Still disease-like manifestations 44
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study 36
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 29
Totale 15.420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.486
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021998 0 0 0 0 0 99 173 147 118 188 161 112
2021/20221.535 118 65 85 85 272 92 92 141 87 151 116 231
2022/20232.283 184 88 85 149 170 168 108 198 626 164 170 173
2023/20241.960 126 94 155 190 292 83 177 213 128 146 188 168
2024/20252.775 122 174 119 183 365 312 285 238 355 251 232 139
2025/20262.554 289 317 304 329 524 791 0 0 0 0 0 0
Totale 15.420